Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.39 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.38 |
| ▸ | PHGDH | O43175 | 1/20 | 0.38 |
| ▸ | TEAD1 | P28347 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32661153 | 0.82 | ALDH1A1 (0.49) | KDM4EALDH1A1KCNH2ADRB2HRH3 | |
| SCHEMBL32661396 | 0.82 | ALDH1A1 (0.49) | KDM4EALDH1A1KCNH2ADRB2HRH3 | |
| SCHEMBL32661277 | 0.82 | ALDH1A1 (0.49) | KDM4EALDH1A1KCNH2ADRB2HRH3 | |
| SCHEMBL32661370 | 0.82 | ALDH1A1 (0.49) | KDM4EALDH1A1KCNH2ADRB2HRH3 | |
| SCHEMBL32661494 | 0.82 | ALDH1A1 (0.49) | KDM4EALDH1A1KCNH2ADRB2HRH3 | |
| SCHEMBL32661179 | 0.82 | ALDH1A1 (0.49) | KDM4EALDH1A1KCNH2ADRB2HRH3 | |
| SCHEMBL29087753 | 0.77 | HIF1A (0.41) | KDM4EALDH1A1DNMT1EHMT2L3MBTL1 | |
| SCHEMBL29087751 | 0.77 | HIF1A (0.41) | KDM4EALDH1A1DNMT1EHMT2L3MBTL1 | |
| SCHEMBL32661400 | 0.74 | KDM4E (0.45) | KDM4EALDH1A1KCNH2HRH3TEAD1 | |
| SCHEMBL32661252 | 0.74 | KDM4E (0.45) | KDM4EALDH1A1KCNH2HRH3TEAD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015323-A1 | PIPERIDINE COMPOUNDS | TELO THERAPEUTICS INC (US) | 2026-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015323-A1 | PIPERIDINE COMPOUNDS | XPO1, NR0B1, NR2E1 | KDM4E 3383/4885ALDH1A1 1959/4885KCNH2 1129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.